Contributor Page
Ropes & Gray LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
NY 10036-8704
United States
By Scott A. McKeown
Last September, the Patent Trial & Appeal Board (PTAB) held that the advanced state of a district court proceeding militated in favor of denying a petition for IPR in accordance
By Ropes & Gray LLP's Intellectual Property Practice
In a precedential opinion, the Federal Circuit on December 7, 2018 reversed the final determination of the U.S. International Trade Commission (ITC) ...
By David G. Tittsworth, Joel Wattenbarger
This Ropes & Gray podcast series, which we expect to update periodically, will highlight developments in Washington, D.C. that affect private funds and their legal, regulatory and compliance obligations.
By Thomas N. Bulleit, Kirsten Mayer, Deborah Kantar Gardner, Scott Falin (Law Clerk)
Donald Trump's election in 2016 placed pharmaceutical companies in uncharted territory. Unlike predecessors from both major political parties, Trump did not shy away from directly criticizing the industry.
By Michael B. Lampert, Whitney N. Wadman, Cara Dermody, Wesley Dodd
On Dec. 21, 2018, the Centers for Medicare & Medicaid Services issued a final rule1 establishing the "Pathways to Success" program, which overhauls the Medicare shared savings program, or MSSP
By Scott A. McKeown
Post SAS, there are fewer exceptions to IPR estoppel. Indeed, the absence of partial institutions has led to many courts finding the "reasonably could have raised" ...
By Ryan Rohlfsen, Patrick J. Reinikainen, Daniel Flaherty
First, Cronan discussed a company that allegedly aided and abetted fraudulent payments involving its corrupt agents and customers.
By Katherine Wang
China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies.
By Nicholas Berg, Jeffrey J. Bushofsky, Laura Hoey, Ryan Rohlfsen, Timothy Farrell, Philip P. Ehrlich
Beginning last month, the Northern District of Illinois (or the "Court") modified its Mandatory Initial Discovery Pilot Project (the "Pilot Project") in ways that should come as a relief to corporate
By Scott A. McKeown
After Octane Fitness, district courts "may determine whether a case is ‘exceptional' in the case-by-case exercise of their discretion, considering the totality of the circumstances."
By Ropes & Gray LLP's Health Care Practice, Ropes & Gray LLP's Life Sciences Practice Group
On December 20, 2018, President Trump signed the Agriculture Improvement Act of 2018 (P.L. 115-332), commonly referred to as the "2018 Farm Bill," into law
By Ropes & Gray LLP's Investment Management Practice Group
On December 20, 2018, the SEC staff issued a no-action letter to Madison Capital Funding LLC ("Madison"), a registered investment adviser ...
By Ropes & Gray LLP's Tax-Exempt Organizations
In Notice 2019-09, issued December 31, 2018 (the "Notice"), Treasury and the IRS have provided interim guidance on the excise tax on certain executive compensation arrangements
By Scott A. McKeown
Patent pools and groupings of standard essential patents (SEPs) facilitate one-stop shopping of patent licensees.
By Deborah Monson, Jeremy A. Liabo, Anne Fox, Erin Conklin
In the final weeks of 2018, the National Futures Association ("NFA") issued new requirements applicable to asset managers who are members of the NFA that will take effect in 2019.
Contributor's Topics